Covalent cDNA Linking for Immune Repertoire Pairing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for high-throughput capture of immune repertoire sequences face issues with mispairing and loss of transcripts due to non-covalent attachment of mRNA to capture beads, leading to reduced sensitivity and accuracy in immune cell sequence pairing.

Innovation Solution

The method involves isolating a single cell, lysing it to release mRNA, and then reverse transcribing the mRNA into cDNA that is covalently attached to a solid support within a first container, followed by linking the cDNA molecules in a second container, thereby producing linked nucleic acid molecules that are highly sensitive and reduce transcript loss and mispairing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If mRNA transcripts are non-covalently attached to capture beads, then the capture process is simple and efficient, but transcript loss and mispairing occur due to dehybridization and random binding

Engineering Contradiction:
Improvecapture process simplicityVSAvoidtranscript pairing accuracy
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent performs reverse transcription to convert mRNA to cDNA before the beads leave the first container. This preliminary conversion ensures that the genetic information is captured in a stable form before any potential transcript loss or mispairing can occur during bead handling and washing steps.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent creates a complementary DNA copy (cDNA) of the mRNA transcript. This copying process preserves the genetic information in a more stable molecule that is less prone to degradation and dehybridization issues, thereby maintaining pairing accuracy through subsequent processing steps.

Inventive Principle:
Principle #26Copying

2Adaptability or versatility

If mRNA transcripts are kept in solution between containers, then the workflow is flexible, but transcripts are vulnerable to degradation by RNases and dehybridization

Engineering Contradiction:
Improveworkflow flexibilityVSAvoidtranscript degradation and dehybridization
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The patent creates a complementary DNA copy (cDNA) of the mRNA transcript. This copying process preserves the genetic information in a more stable molecule that is less prone to degradation and dehybridization issues, thereby maintaining pairing accuracy through subsequent processing steps.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent changes the chemical state of the transcript from RNA to DNA through reverse transcription. DNA is inherently more stable than RNA and resistant to RNase degradation, allowing the material to withstand flexible workflow conditions including multiple washing steps and extended processing times without loss of integrity.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If excess transcripts remain free in solution, then capture efficiency does not need to be 100%, but free transcripts can bind randomly to other beads causing mispairing

Engineering Contradiction:
Improvecapture efficiencyVSAvoidtranscript pairing fidelity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent performs reverse transcription to convert mRNA to cDNA while the beads are still in the first container, before any washing or re-encapsulation steps. This preliminary action ensures that even if some transcripts are lost or mispaired during handling, the majority that were correctly captured will have their information preserved in cDNA form, maintaining overall pairing fidelity.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly increases the percentage of correctly linked amplicons from the same cell, improving the fidelity and sensitivity of immune cell receptor sequence pairing, and provides a more robust and flexible workflow.

Implementation Method 1

hybridizing the mRNA molecules to a capture oligonucleotide attached to a solid support, wherein the capture oligonucleotide comprises a sequence complementary to a portion of the mRNA sequence

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

reverse transcribing the mRNA molecules to produce cDNA molecules in the first container

Methodology Applied
Scientific EffectReverse transcription: Enzyme

Implementation Method 3

reverse transcribing the mRNA molecules to produce cDNA molecules in the first container... thereby producing linked nucleic acid molecules that are highly sensitive and reduce transcript loss and mispairing

Methodology Applied
Scientific EffectCovalent attachment: Chemical Bonding

Data Source

PatentUS20230220376A1High throughput linking of multiple transcripts
Publication Date: 2023.07.13 ATRECA INC
  • US20230220376A1 patent drawing
  • US20230220376A1 patent drawing
  • US20230220376A1 patent drawing

AI summary

Provided are high throughput methods for physically linking cDNA molecules derived from mRNA molecules expressed by the same cell, and libraries of linked cDNA molecules produced by the methods. The methods comprise reverse transcribing mRNA from a single cell in a first container to produce cDNA molecules, and linking the cDNA molecules in a second container. The methods unexpectedly produced libraries of cDNA molecules with an increase in the number of molecules that are correctly linked to other molecules derived from the same cell.